Literature DB >> 32173232

Squamous cell carcinoma transformation after acquired resistance to osimertinib in a patient with lung adenocarcinoma harboring uncommon EGFR mutation.

Chi-Lu Chiang1, Yi-Chen Yeh2, Teh-Ying Chou3, Chao-Hua Chiu4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32173232     DOI: 10.1016/j.jfma.2019.12.017

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


× No keyword cloud information.
  2 in total

Review 1.  T790M mutation positive squamous cell carcinoma transformation from EGFR-mutated lung adenocarcinoma after low dose erlotinib: A case report and literature review.

Authors:  Yusaku Kusaba; Yuichiro Takeda; Sakurako Abe; Akinari Tsukada; Go Naka
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

2.  Transformation of adenocarcinoma to squamous cell carcinoma as a source of EGFR-TKI resistance: A case report and literature review.

Authors:  Yun-Zhu Xi; Li Xie; Xiao-Wu Tan; Sai-Li Zeng
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.